Mechanism underlying the block of human Cav3.2 T-type Ca2+ channels by benidipine, a dihydropyridine Ca2+ channel blocker

Akizuki, 2008, Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R, Eur J Pharmacol, 584, 424, 10.1016/j.ejphar.2008.02.001 Arrowsmith, 1986, Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents, J Med Chem, 29, 1696, 10.1021/jm00159a022 Catterall, 2000, Structure and regulation of voltage-gated Ca2+ channels, Annu Rev Cell Dev Biol, 16, 521, 10.1146/annurev.cellbio.16.1.521 Catterall, 2005, International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels, Pharmacol Rev, 57, 411, 10.1124/pr.57.4.5 Chemin, 2000, Overexpression of T-type calcium channels in HEK-293 cells increases intracellular calcium without affecting cellular proliferation, FEBS Lett, 478, 166, 10.1016/S0014-5793(00)01832-9 Freeze, 2006, State-dependent verapamil block of the cloned human Cav3.1T-type Ca2+ channel, Mol Pharmacol, 70, 718, 10.1124/mol.106.023473 Furukawa, 2004, Identification of R(−)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels, Br J Pharmacol, 143, 1050, 10.1038/sj.bjp.0705944 Furukawa, 2005, Differential blocking action of dihydropyridine Ca2+ antagonists on a T-type Ca2+ channel (α1G) expressed in Xenopus oocytes, J Cardiovasc Pharmacol, 45, 241, 10.1097/01.fjc.0000154374.88283.15 Furukawa, 2009, Five different profiles of dihydropyridines in blocking T-type Ca2+ channel subtypes (Cav3.1 (α1G), Cav3.2 (α1H), and Cav3.3 (α1I)) expressed in Xenopus oocytes, Eur J Pharmacol, 613, 100, 10.1016/j.ejphar.2009.04.036 Gomora, 2000, Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca2+ channels in cortisol-secreting cells, J Pharmacol Exp Ther, 292, 96 Hayashi, 2007, Ca2+ channel subtypes and pharmacology in the kidney, Circ Res, 100, 342, 10.1161/01.RES.0000256155.31133.49 Ishii, 1988, Receptor binding properties of the new calcium antagonist benidipine hydrochloride, Arzneimittelforschung, 38, 1677 Kawata, 1997, Diversity in the renal hemodynamic effects of dihydropyridine calcium blockers in spontaneously hypertensive rats, J Cardiovasc Pharmacol, 30, 431, 10.1097/00005344-199710000-00005 Kumar, 2002, Synthesis and evaluation of a new class of nifedipine analogs with T-type calcium channel blocking activity, Mol Pharmacol, 61, 649, 10.1124/mol.61.3.649 Martin, 2000, Mibefradil block of cloned T-type calcium channels, J Pharmacol Exp Ther, 295, 302 Masumiya, 2000, Frequency-dependent blockade of T-type Ca2+ current by efonidipine in cardiomyocytes, Life Sci, 68, 345, 10.1016/S0024-3205(00)00932-2 Morikawa, 2002, Effects of benidipine on glomerular hemodynamics and proteinuria in patients with nondiabetic nephropathy, Hypertens Res, 25, 571, 10.1291/hypres.25.571 Muto, 1988, Synthesis and pharmacological activity of stereoisomers of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 1-(phenylmethyl)-3-piperidinyl ester, Arzneimittelforschung, 38, 1662 Ono, 2005, Pathophysiological significance of T-type Ca2+ channels: properties and functional roles of T-type Ca2+ channels in cardiac pacemaking, J Pharmacol Sci, 99, 197, 10.1254/jphs.FMJ05002X2 Perez-Reyes, 2003, Molecular physiology of low-voltage-activated T-type calcium channels, Physiol Rev, 83, 117, 10.1152/physrev.00018.2002 Perez-Reyes, 2009, Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs, J Pharmacol Exp Ther, 328, 621, 10.1124/jpet.108.145672 Shcheglovitov, 2005, Contrasting the effects of nifedipine on subtypes of endogenous and recombinant T-type Ca2+ channels, Biochem Pharmacol, 69, 841, 10.1016/j.bcp.2004.11.024 Shin, 2008, T-type Ca2+ channels as therapeutic targets in the nervous system, Curr Opin Pharmacol, 8, 33, 10.1016/j.coph.2007.12.003 Triggle, 1999, The pharmacology of ion channels: with particular reference to voltage-gated Ca2+ channels, Eur J Pharmacol, 375, 311, 10.1016/S0014-2999(99)00329-5 Uzu, 2007, Benidipine attenuates glomerular hypertension and reduces albuminuria in patients with metabolic syndrome, Hypertens Res, 30, 161, 10.1291/hypres.30.161 Vassort, 2006, Role of T-type Ca2+ channels in the heart, Cell Calcium, 40, 205, 10.1016/j.ceca.2006.04.025 Xia, 2003, Generation and characterization of a cell line with inducible expression of Cav3.2 (T-type) channels, Assay Drug Dev Technol, 1, 637, 10.1089/154065803770380995 Xie, 2007, Validation of high throughput screening assays against three subtypes of Cav3 T-type channels using molecular and pharmacologic approaches, Assay Drug Dev Technol, 5, 191, 10.1089/adt.2006.054 Yao, 2006, Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker, J Pharmacol Sci, 100, 243, 10.1254/jphs.DTJ05001X